NIAID chooses Fujitsu for healthcare optical network

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has chosen technology and services from Fujitsu Network Communications for a multi-node regional fiber-optic network. The high-speed network is designed to enable researchers to access and share data residing in remote datacenters.

Fujitsu will supply its FLASHWAVE 7420 Metro/Enterprise WDM Platform, NETSMART 1500 Management System, and a varity of professional services for the network, which will be capable of transmitting data at 40 Gbps with sub-microsecond latency. The network also will supply multi-protocol, multi-application support as well as remote monitoring and management.

NIAID conducts and supports research to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses.

“Many organizations today are not looking for a vendor, they’re looking for a partner,” said Paul Fagan, senior vice president of sales at Fujitsu Network Communications. “Our work with NIAID is a prime example. We are working side-by-side to architect the network, implement the technology - both hardware and software - and train staff. Our commitment is to ensure NIAID’s fiber-optic infrastructure fully supports the critical work being done there.”

Fujitsu’s FLASHWAVE 7420 DWDM platform includes reconfigurable optical add/drop multiplexer (ROADM) technology and supports Ethernet, SONET/SDH, G.709 OTN, ATM, video, and SAN protocols. Its NETSMART 1500 carrier-class management system will enable NIAID to remotely monitor, manage, provision, and maintain the FLASHWAVE 7420.

In addition to planning and deploying network hardware and software, Fujitsu professional services will provide training on application and equipment engineering, turn-up, operations, and maintenance.

For more information on high-speed transmission equipment and suppliers, visit the Lightwave Buyers Guide.